TY  - JOUR
AU  - Obrecht-Sturm, Denise
AU  - Schömig, Lena
AU  - Mynarek, Martin
AU  - Bison, Brigitte
AU  - Schwarz, Rudolf
AU  - Pietsch, Torsten
AU  - Pfister, Stefan M
AU  - Sill, Martin
AU  - Sturm, Dominik
AU  - Sahm, Felix
AU  - Kortmann, Rolf-Dieter
AU  - Gerber, Nicolas U
AU  - von Bueren, André O
AU  - Fleischhack, Gudrun
AU  - Schüller, Ulrich
AU  - Nussbaumer, Gunther
AU  - Benesch, Martin
AU  - Rutkowski, Stefan
TI  - Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment.
JO  - Neuro-Oncology
VL  - 26
IS  - 9
SN  - 1522-8517
CY  - Oxford
PB  - Oxford Univ. Press
M1  - DZNE-2024-01108
SP  - 1712 - 1722
PY  - 2024
AB  - This study aims at clarifying the impact of persistent residual lesions following first-line treatment for pediatric medulloblastoma.Data on 84 pediatric patients with medulloblastoma and persistent residual lesions on centrally reviewed magnetic resonance imaging (MRI) at the end of first-line therapy were analyzed.Twenty patients (23.8
KW  - Humans
KW  - Medulloblastoma: diagnostic imaging
KW  - Medulloblastoma: pathology
KW  - Male
KW  - Child
KW  - Female
KW  - Magnetic Resonance Imaging: methods
KW  - Cerebellar Neoplasms: diagnostic imaging
KW  - Cerebellar Neoplasms: pathology
KW  - Disease Progression
KW  - Child, Preschool
KW  - Adolescent
KW  - Follow-Up Studies
KW  - Prognosis
KW  - Retrospective Studies
KW  - Survival Rate
KW  - Infant
KW  - Neoplasm, Residual: diagnostic imaging
KW  - Neoplasm, Residual: pathology
KW  - MRI (Other)
KW  - children (Other)
KW  - medulloblastoma (Other)
KW  - persistent residual disease (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:38578306
C2  - pmc:PMC11376455
DO  - DOI:10.1093/neuonc/noae071
UR  - https://pub.dzne.de/record/271966
ER  -